• Human SIRP Gamma/CD172g protein (Recombinant) (C-His & Avi) (STJP002367)
  • Human SIRP Gamma/CD172g protein (Recombinant) (C-His & Avi) (STJP002367)
  • Human SIRP Gamma/CD172g protein (Recombinant) (C-His & Avi) (STJP002367)

Human SIRP Gamma/CD172g protein (Recombinant) (C-His & Avi) (STJP002367)

SKU:
STJP002367-100

Shipping:
Free Shipping
Current Stock:
Host: HEK293 cells
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Recombinant-Human SIRP Gamma/CD172g-C-His & Avi protein was developed from hek293 cells and has a target region of C-His & Avi. For use in research applications.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Endotoxin: Less than 1EU per Mu g by the LAL method.
Gene Symbol: SIRPG
Gene ID: 55423
Uniprot ID: SIRPG_HUMAN
Immunogen Region: Glu29-Pro360
Immunogen: Recombinant Human SIRP Gamma/CD172g Protein is expressed from Expi293 with His tag and Avi tag at the C-terminal.;It contains Glu29-Pro360.
Function Probable immunoglobulin-like cell surface receptor. On binding with CD47, mediates cell-cell adhesion. Engagement on T-cells by CD47 on antigen-presenting cells results in enhanced antigen-specific T-cell proliferation and costimulates T-cell activation.
Protein Name Signal-Regulatory Protein Gamma
Sirp-Gamma
Cd172 Antigen-Like Family Member B
Signal-Regulatory Protein Beta-2
Sirp-B2
Sirp-Beta-2
Cd Antigen Cd172g
Database Links Reactome: R-HSA-202733
Reactome: R-HSA-391160
Cellular Localisation Membrane
Single-Pass Type I Membrane Protein
Alternative Protein Names Signal-Regulatory Protein Gamma protein
Sirp-Gamma protein
Cd172 Antigen-Like Family Member B protein
Signal-Regulatory Protein Beta-2 protein
Sirp-B2 protein
Sirp-Beta-2 protein
Cd Antigen Cd172g protein
SIRPG protein
SIRPB2 protein

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance